Trial · Interventional
Status unknownPhase 4Registry dataIntravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
Overview
- Status
- Status unknown
- Phase
- Phase 4
- Enrollment
- 100 participants
- Sponsor
- National Taiwan University Hospital · Other
- Design
- Randomized · Double masking
- Countries
1 country
Taiwan
- Start
- Sept 2005
- Primary completion
- Not stated
- Completion
- Sept 2005
- First posted
- 12 Sept 2005 (estimated)
- Last update posted
- 28 Nov 2005 (estimated)
- Conditions
- Liver Disease
Timeline
1 trial
- Completed
- Ongoing
- Not yet recruiting
- Stopped
- Estimated dates (est.)
- Results posted
- Ph 4
Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
NCT00155376Sept 2005 to Sept 2005
Registry summary
Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.
Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.
Interventions
- morphine and glucagonDrug
Arms0
The registry lists no arms for this trial.
Primary outcomes1
Outcomes the sponsor listed as primary.
MRCP visibility
Posted results
Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.
No results are posted for this trial.
A trial that is still running, or that stopped early, may post results later.
Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works
Studies0
Studies that cite this trial.
No study cites this trial.
Eligibility
Who could join, as posted.
- Sex
- All
- Age
- from 20 Years up to 75 Years
- Healthy volunteers
- Accepted
Inclusion and exclusion criteria, as posted
PepBank is a research reference. Talk to a doctor before you use any peptide.